Tobacco consumption is a reversible risk factor associated with reduced successful treatment outcomes of anti-tuberculosis therapy
Author(s) -
Yi-Chun Chiang,
You-Meei Lin,
JenAi Lee,
Chun-Nin Lee,
HsiangYin Chen
Publication year - 2011
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2011.10.007
Subject(s) - medicine , odds ratio , ethambutol , tuberculosis , risk factor , retrospective cohort study , adverse effect , surgery , mycobacterium tuberculosis , pathology
The aim of this study was to evaluate the reversible factors that could possibly affect outcomes of anti-tuberculosis (anti-TB) treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom